Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-011019
Filing Date
2014-02-14
Accepted
2014-02-14 19:57:46
Documents
1
Period of Report
2014-02-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3727
  Complete submission text file 0001209191-14-011019.txt   5276
Mailing Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656
Business Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656 949-389-6700
AVANIR PHARMACEUTICALS, INC. (Issuer) CIK: 0000858803 (see all company filings)

EIN.: 330314804 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address 60 WEST 66TH STREET, 26A NEW YORK NY 10023
Business Address
Bishop Hans Edgar (Reporting) CIK: 0001480212 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15803 | Film No.: 14619870